Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Capricor Therapeutics, Inc. (CAPR) vs REGENXBIO Inc. (RGNX)

Capricor Therapeutics, Inc. and REGENXBIO Inc. are both Biotechnology companies. Capricor Therapeutics, Inc. and REGENXBIO Inc. are of similar size ($508.7M and $487.8M). REGENXBIO Inc. grew revenue faster over the last twelve months: 12.0% against −11.6%. Capricor Therapeutics, Inc. has the higher net margin (0.00% vs −112.6%) and the lower return on invested capital (−1,019.7% vs 0.00%). Across the 17 metrics below, Capricor Therapeutics, Inc. leads on 10 and REGENXBIO Inc. on 7.

Valuation

Metric CAPR RGNX Biotechnology median
P/E n/m n/m 7.88
P/S 21.74 2.24 11.47
P/B 1.97 5.45 2.52
Price to free cash flow 3.70 n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 11.32 2.12 10.73
Earnings yield (29.31%) (51.22%) (28.84%)
Free cash flow yield 27.03% (63.88%) (23.03%)

Profitability

Metric CAPR RGNX Biotechnology median
Gross margin 100.00% 86.38% 65.16%
Operating margin 0.00% (94.08%) 0.00%
Net margin 0.00% (112.58%) 0.00%
Free cash flow margin 0.00% (143.09%) 0.00%
Return on equity (73.70%) (137.63%) (57.72%)
Return on assets (51.53%) (40.60%) (49.22%)
Return on invested capital (1,019.73%) 0.00% 0.00%

Growth

Metric CAPR RGNX Biotechnology median
Revenue growth (TTM) (11.55%) 12.00% 5.64%
EPS growth (last fiscal year) (96.52%) 18.08% —
Revenue growth, 5-year CAGR 85.83% 1.97% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CAPR RGNX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.35 2.86 4.73
Net debt to EBITDA 2.99 1.58 0.96

Dividend

Metric CAPR RGNX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CAPR RGNX Biotechnology median
Market cap 508.72m 487.84m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack